Please don't hesitate to contact us if you have any questions or other inquiries.

Nordic Bioscience is participating in 2022 ASCO

Our team is looking forward to participating at 2022 ASCO, the world's premier oncology research event. This year the meeting's theme: Advancing Equitable Cancer Care Through Innovation. The team will be present in Chicago in person and are excited to meet the greatest scientific minds of the cancer research field.

We are happy to announce that the following two posters will showcase Nordic Bioscience data from our latest research:

Abstract Number for Publication: 4082

Abstract Title: The potential use of blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer.

Session Title: Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Session Date and Time:
Saturday, June 4, 2022, 8:00 AM-11:00 AM CDT

Troels Dreier Christensen, Copenhagen University Hospital

Abstract Number for Publication: 2059

Abstract Title: Indirect assessment of tumor-infiltrating lymphocyte activity in serum for predicting outcome in glioblastoma patients treated with immunotherapy in the recurrent setting.

Session Title: Central Nervous System Tumors

Session Date and Time:
Sunday, June 5, 2022, 8:00 AM-11:00 AM CDT

Nicholas Willumsen / Neel I. Nissen, Nordic Bioscience


We are looking forward to meeting you!

Please don't hesitate to contact us if you have any questions or other inquiries.

Are you interested in learning more about Nordic Bioscience?
Enter your information in the form and a representative will contact you shortly.

By submitting this form you agree to our terms and conditions.